The Role of Anti-cyclic Citrullinated Peptide Antibody from Joint to Brain

The Role of Anti-cyclic Citrullinated Peptide Antibody from Joint to Brain

Background: Anti-cyclic citrullinated peptide (CCP) antibodies are highly specific and predictive for rheumatoid arthritis (RA). Recently, existence of anti-CCP in several other inflammatory conditions from psoriatic arthritis to neurodegenerative disorder like Alzheimer's disease (AD) has been...

Full description

Bibliographic Details
Main Authors:	Rokhsareh Meamar, Mohammadreza Maracy, Majid Ghasemi, Mansour Salesi
Format:	Article
Language:	fas
Published:	Vesnu Publications 2014-02-01
Series:	مجله دانشکده پزشکی اصفهان
Subjects:	Anti-cyclic citrullinated peptide (CCP) Arthritis rheumatoid Memory impairment
Online Access:	http://jims.mui.ac.ir/index.php/jims/article/view/3263

Similar Items

Antibodies to cyclic citrullinized peptide in rheumatoid arthritis
by: E N Aleksandrova, et al.
Published: (2004-12-01)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
by: Pureun Won, et al.
Published: (2021-06-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
by: Tebo Anne E, et al.
Published: (2012-08-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013-03-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
by: Nicole H. Trier, et al.
Published: (2017-03-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
by: Mehanović-Nikolić Jasminka, et al.
Published: (2008-01-01)

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis
by: Tomoya Shibahara, et al.
Published: (2016-07-01)

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS
by: S O Salugina, et al.
Published: (2009-06-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
by: Hisakata Yamada, et al.
Published: (2020-04-01)

Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017-04-01)

Is anti-cyclic citrullinated peptide antibody a good value biomarker for alzheimer disease?
by: Rokhsareh Meamar, et al.
Published: (2013-01-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

The Contribution of Serum Anti–cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 in Predicting the Activity of Rheumatoid Arthritis Disease
by: Aida R. Al-Derzi
Published: (2017-07-01)

Diagnostic utility of Anti-cyclic Citrullinated Peptide Antibodies for Very Early Rheumatoid Arthritis
by: Sucilathangam G, et al.
Published: (2014-07-01)

Independence of carbohydrate-deficient isoforms of transferrin and cyclic citrullinated peptides in rheumatoid arthritis
by: Monika Gudowska, et al.

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
by: Ilaria Fanelli, et al.
Published: (2021-07-01)

Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs
by: Nasrin Moghimi, et al.
Published: (2013-10-01)

Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependency
by: Takeshi Iwasaki, et al.
Published: (2020-10-01)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
by: Nicole H. Trier, et al.
Published: (2019-06-01)

The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis
by: Xuan Tang, et al.
Published: (2021-06-01)

Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis
by: Sarah Twigg, et al.
Published: (2018-02-01)

Anti-cyclic citrullinated peptide antibodies in ulcerative colitis with and without joint involvement
by: Tarek A Fouad, et al.
Published: (2018-01-01)

ACPAs Are Much More Than Diagnostic Autoantibodies
by: Abdulla Watad, et al.
Published: (2016-10-01)

Effect of denosumab switched from bisphosphonates in preventing joint destruction in postmenopausal rheumatoid arthritis patients with anti-cyclic citrullinated peptide antibodies
by: Yu Mori, et al.
Published: (2021-02-01)

Synovial fluid anti-citrulline-containing peptide antibody and its role in the diagnosis of rheumatoid arthritis
by: Ali I Fouda, et al.
Published: (2017-01-01)

Significance of anti-cyclic citrullinated peptide autoantibodies in immune-mediated inflammatory skin disorders with and without arthritis
by: Chander Grover, et al.
Published: (2016-01-01)

The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates
by: Zintzaras Elias, et al.
Published: (2012-06-01)

Antibodies to citrullinated peptides are not associated with the rate of joint destruction in patients with a well-established diagnosis of rheumatoid arthritis
by: A.M. Nieto-Colonia, et al.
Published: (2008-03-01)

The impact of anti-cyclic citrullinated peptide antibody status on the management of patients with early rheumatoid arthritis: observational study results from Lithuania
by: Sigita Stropuvienė, et al.
Published: (2018-08-01)

Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients?
by: Leonor Nogueira, et al.
Published: (2021-01-01)

Affinity Purification and Comparative Biosensor Analysis of Citrulline-Peptide-Specific Antibodies in Rheumatoid Arthritis
by: Eszter Szarka, et al.
Published: (2018-01-01)

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance
by: Laura Martinez-Prat, et al.
Published: (2018-06-01)

The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis
by: Stamenković Bojana, et al.
Published: (2012-01-01)

Electrochemical Immunosensor for the Early Detection of Rheumatoid Arthritis Biomarker: Anti-Cyclic Citrullinated Peptide Antibody in Human Serum Based on Avidin-Biotin System
by: Somasekhar R. Chinnadayyala, et al.
Published: (2021-12-01)

The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients
by: Nasrin Iranshahi, et al.
Published: (2018-01-01)

Effect of anti - cyclic citrullinated peptide antibody and Rheumatoid factor on clinical diseases activity index in patients with rheumatoid arthritis
by: Jafarzadeh L, et al.
Published: (2015-09-01)

Valor diagnóstico do anticorpo antipeptídeo citrulinado cíclico na artrite reumatóide Diagnostic value of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis
by: Aldifran Ferreira da Silva, et al.
Published: (2006-06-01)